Titles and Roles
- Assistant Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Research Program
- Discovery and Developmental Therapeutics
Natalyn Hawk, MD, PhD, completed a one year post-doctoral fellowship at Emory University where she conducted pre-clinical investigations on the effects of combined inhibition of mTOR and EGF receptor on the growth of non small cell lung cancer cells. She subsequently completed a three year fellowship in hematology and medical oncology at Emory University in 2010 and is board certified in hematology and medical oncology. She is involved in designing, opening and conducting studies whose focus involves patients with recurrent or refractory soft tissue sarcomas, including patients with gastrointestinal stromal tumors (GIST).
Dr. Hawk obtained her MD and PhD from Brown University in Providence, Rhode Island, during which she conducted her PhD research on protein-protein interactions in chronic myeloid leukemia as a visiting scientist at M.D. Anderson Cancer Center in Houston, Texas. She completed residency training in internal medicine at Johns Hopkins Bayview Medical Center in Baltimore, MD.
Dr. Hawk has a broad variety of clinical research interests. As a member of the GI Oncology Working Group, she has designed an early phase protocol utilizing a multi-disciplinary approach involving sequentially delivered chemotherapy and stereotactic radiotherapy for the neoadjuvant treatment of patients with pancreas cancer. As a separate project, she is investigating the impact of age on the outcome of patients with advanced colon cancer.